000 01355 a2200373 4500
005 20250513134536.0
264 0 _c19980414
008 199804s 0 0 eng d
022 _a0269-2139
024 7 _a10.1093/protein/10.9.1071
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVallera, D A
245 0 0 _aRenal dysfunction accounts for the dose limiting toxicity of DT390anti-CD3sFv, a potential new recombinant anti-GVHD immunotoxin.
_h[electronic resource]
260 _bProtein engineering
_cSep 1997
300 _a1071-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aCD3 Complex
_xtoxicity
650 0 4 _aDiphtheria Toxin
_xtoxicity
650 0 4 _aGraft vs Host Disease
_xtherapy
650 0 4 _aImmunoglobulin Fragments
_xtoxicity
650 0 4 _aImmunotoxins
_xtoxicity
650 0 4 _aKidney
_xdrug effects
650 0 4 _aLiver
_xdrug effects
650 0 4 _aMacrophages
_xdrug effects
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, SCID
650 0 4 _aRecombinant Fusion Proteins
_xtoxicity
700 1 _aPanoskaltsis-Mortari, A
700 1 _aBlazar, B R
773 0 _tProtein engineering
_gvol. 10
_gno. 9
_gp. 1071-6
856 4 0 _uhttps://doi.org/10.1093/protein/10.9.1071
_zAvailable from publisher's website
999 _c9433542
_d9433542